MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30.

Income Overview

Net Income
-$4,301K
EPS
-$0.32
Unit: Thousand (K) dollars

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2024-12-31
2024-09-30
Total revenue
--29,583 40,190
Commercialization revenue
3,453 17,575 --
Cost of commercialization revenue
115 554 4,469 7,602
Research and development expenses
2,925 7,310 35,853 43,924
General and administrative expenses
3,987 6,514 9,822 10,421
Total costs and operating expenses
7,027 14,378 50,144 61,947
Income (loss) from operations
-3,574 3,197 -20,560 -21,757
Interest income
204 143 550 459
Interest expense
909 972 1,144 1,183
Other income (expense), net
4 22 -9 555
Total other income (expense), net
-701 -807 -603 -169
Income (loss) before provision for (benefit from) income taxes
-4,275 2,390 -21,163 -21,926
Provision for (benefit from) income taxes
28 3 2 -17
Net income (loss)
-4,303 2,387 -21,165 -21,909
Unrealized gain (loss) on available-for-sale securities
2 0 59 36
Comprehensive income (loss)
-4,301 2,387 -21,106 -21,873
Earnings per share, basic
-0.32 0.2 -2.827 -2.93
Earnings per share, diluted
-0.32 0.19 -2.827 -2.93
Weighted average shares outstanding - basic
13,564,000 12,197,000 7,333.333 7,466,000
Weighted average shares outstanding - diluted
13,564,000 12,310,000 7,333.333 7,466,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive income (loss)-$4,301K Unrealized gain (loss) onavailable-for-sale securities$2K Net income (loss)-$4,303K Provision for (benefitfrom) income taxes$28K Income (loss) beforeprovision for (benefit...-$4,275K Total other income(expense), net-$701K Income (loss) fromoperations-$3,574K Other income(expense), net$4K Interest income$204K Commercialization revenue$3,453K Interest expense$909K Total costs andoperating expenses$7,027K General andadministrative expenses$3,987K Research and developmentexpenses$2,925K Cost ofcommercialization revenue$115K

Atara Biotherapeutics, Inc. (ATRA)

Atara Biotherapeutics, Inc. (ATRA)